These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 30958867)
1. Biphasic and cardiomyocyte-specific IFIT activity protects cardiomyocytes from enteroviral infection. Kimura T; Flynn CT; Alirezaei M; Sen GC; Whitton JL PLoS Pathog; 2019 Apr; 15(4):e1007674. PubMed ID: 30958867 [TBL] [Abstract][Full Text] [Related]
2. In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease. Althof N; Harkins S; Kemball CC; Flynn CT; Alirezaei M; Whitton JL J Virol; 2014 May; 88(9):5087-99. PubMed ID: 24574394 [TBL] [Abstract][Full Text] [Related]
3. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis. Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795 [TBL] [Abstract][Full Text] [Related]
4. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas. Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635 [TBL] [Abstract][Full Text] [Related]
5. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production. Liu H; Li M; Song Y; Xu W Front Immunol; 2018; 9():2479. PubMed ID: 30410495 [TBL] [Abstract][Full Text] [Related]
8. The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity. Valaperti A; Nishii M; Liu Y; Yang H; Naito K; Liu PP; Eriksson U Basic Res Cardiol; 2014 May; 109(3):411. PubMed ID: 24763933 [TBL] [Abstract][Full Text] [Related]
10. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. Tracy S; Höfling K; Pirruccello S; Lane PH; Reyna SM; Gauntt CJ J Med Virol; 2000 Sep; 62(1):70-81. PubMed ID: 10935991 [TBL] [Abstract][Full Text] [Related]
11. Major Group-B Enterovirus populations deleted in the noncoding 5' region of genomic RNA modulate activation of the type I interferon pathway in cardiomyocytes and induce myocarditis. Callon D; Glenet M; Lebreil AL; Heng L; Bouland N; Fichel C; Fornes P; Andreoletti L; Berri F PLoS Pathog; 2024 May; 20(5):e1012125. PubMed ID: 38696536 [TBL] [Abstract][Full Text] [Related]
12. The protection effects of survivin in the cell model of CVB3-induced viral myocarditis. Wu R; Wu T; Li P; Wang Q; Shi Y; Zhan Y; Zhang S; Xia T; Wang Z; Lv H Heart Vessels; 2020 Aug; 35(8):1171-1179. PubMed ID: 32328712 [TBL] [Abstract][Full Text] [Related]
13. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis. Wang Y; Gao B; Xiong S Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1438-47. PubMed ID: 25260607 [TBL] [Abstract][Full Text] [Related]
14. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis. Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436 [TBL] [Abstract][Full Text] [Related]
15. Cardiomyocyte-specific deletion of Senp2 contributes to CVB3 viral replication and inflammation. Wang K; Jiang Z; Lu X; Zhang Y; Yuan X; Luo D; Lin Z; Zuo Y; Luo Q Int Immunopharmacol; 2020 Nov; 88():106941. PubMed ID: 33182061 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes. Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926 [TBL] [Abstract][Full Text] [Related]
17. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis. Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012 [TBL] [Abstract][Full Text] [Related]
18. FTY720 alleviates coxsackievirus B3-induced myocarditis and inhibits viral replication through regulating sphingosine 1-phosphate receptors and AKT/caspase-3 pathways. Wang X; Li M; Yu Y; Liu G; Yu Y; Zou Y; Ge J; Chen R J Cell Physiol; 2019 Aug; 234(10):18029-18040. PubMed ID: 30843214 [TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice. Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649 [TBL] [Abstract][Full Text] [Related]
20. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis. Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]